Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Celgene's Management Is a Strength
Motley Fool
Saturday, March 23, 2013 - 8:58am
tags:
Celgene
GenVec Q4 Net Loss Deepens
Motley Fool
Saturday, March 23, 2013 - 8:56am
tags:
GenVec, earnings
Ariad's Potential Blockbuster Set for EU Debut
Motley Fool
Saturday, March 23, 2013 - 8:54am
tags:
Ariad, Iclusig, chronic myeloid leukemia
Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board
Yahoo/GlobeNewsWire
Saturday, March 23, 2013 - 8:52am
tags:
Gilead Pharmasset, Idenix, hepatitis C, patents
Titan Shares Rise After FDA Panel Backs Opioid Implant
Bloomberg
Saturday, March 23, 2013 - 8:49am
tags:
Titan Pharmaceuticals, Probuphine, opioid addiction
Biogen, Baxter, Sanofi, Gilead Win EU Endorsements
Investors.com
Friday, March 22, 2013 - 11:45am
tags:
Biogen Idec, Baxter International, Sanofi, Gilead, Europe, BG-12, Tecfidera, Aubagio, HyQvia, Halozyme, Stribild
Discovery Laboratories: The Surfaxin Launch And Beyond
Seeking Alpha
Friday, March 22, 2013 - 11:37am
tags:
Surfaxin, Discovery Labs
Medical device maker Cytori loses approval fight
Reuters
Friday, March 22, 2013 - 11:30am
tags:
Cytori, stem cells, devices
EMA rejects Genzyme re-examination request for Kynamro
Yahoo/Fly on the Wall
Friday, March 22, 2013 - 11:29am
tags:
Europe, Genzyme, Kynamro, Sanofi, hypercholesterolemia
Bayer opposes efforts to consolidate IUD lawsuits
Reuters
Friday, March 22, 2013 - 10:57am
tags:
IUD, lawsuits, Bayer
Takeda launches Takeda Ecuador
Pharma Times, UK
Friday, March 22, 2013 - 10:56am
tags:
Takeda, Ecuador
Sanofi’s Lemtrada MS Drug Effective in Extension Trial
Bloomberg
Friday, March 22, 2013 - 10:55am
tags:
Sanofi, Lemtrada, MS, multiple sclerosis
J&J's answer to Botox may escalate war on wrinkles
Reuters
Friday, March 22, 2013 - 10:53am
tags:
JNJ, Botox, Allergan, Mentor, Dysport, Xeomin
Biotechs Get First State Victory Over Biosimilars
Pharmalot
Friday, March 22, 2013 - 10:50am
tags:
biotech, biosimilars, Virginia
Drug Manufacturing Stocks Tumble on FDA Concerns
Yahoo/Accesswire
Friday, March 22, 2013 - 10:49am
tags:
drug manufacturing, Depomed, Novo Nordisk
Trius Therapeutics Is A Strong Investment Short And Long Term
Seeking Alpha
Friday, March 22, 2013 - 10:47am
tags:
Trius Therapeutics, tedizolid
Bayer, J&J’s Xarelto Wins EU Backing for Expanded Use
Bloomberg
Friday, March 22, 2013 - 10:46am
tags:
Bayer, JNJ, Europe, Xarelto, bloodthinners
Bristol-Myers earnings could double by end of decade, says Goldman
Yahoo/Fly on the Wall
Friday, March 22, 2013 - 10:44am
tags:
Bristol-Myers Squibb
US Supreme Court Will Hear 'Pay for Delay' Drug Case
CNBC
Friday, March 22, 2013 - 10:44am
tags:
pay-for-delay, Supreme Court
Dynavax Surprises: Announces Strategic Global Operations Hire
Seeking Alpha
Friday, March 22, 2013 - 10:43am
tags:
Novartis, Dynavax

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.